Tag:
Truvada
Latest Headlines
Latest Headlines
FDA advisory panel backs Truvada for HIV prevention
It is two down and one to go for Truvada, the Gilead Sciences ($GLD) HIV medication. An FDA advisory panel, following the lead of the agency staff, recommended 19-3 that the drug be prescribed to people at high risk as a preventive against HIV infection.
Advisory panels take up Gilead's Truvada, then Quad
It will be up to an advisory panel to say whether Truvada's potential is undercut by the chance patients won't take it or that drug resistance is too likely.
Truvada up for FDA debate as HIV preventive
Should an HIV treatment become a prophylactic? That's the question an FDA panel will address later this week.
AIDS advocates spar over preventive Truvada use
AIDS advocacy groups are dueling over preventive use of Gilead Sciences' ( $GILD ) Truvada , and the FDA is standing right in the line of fire. The agency is considering the company's...
Gilead seeks sNDA for Truvada as HIV prevention
Gilead Sciences is stepping into some controversial waters involving the treatment of HIV. The Foster City, CA, drug company ( $GILD ) wants adults without HIV to be able to use its antiretroviral drug
Truvada fails trial to prevent HIV in women
In disappointing news for AIDS fighters, the Gilead Sciences drug Truvada failed an HIV-prevention trial in high-risk women. The study was stopped early because researchers concluded the drug wasn't
